
Serious liver problems from statins are rare and routine liver monitoring is unnecessary
Louis quotes Harvard Health: among statin users about 1 in 1,000 has an abnormal liver test attributable to the drug, and abnormal results are about as common on placebo. A single baseline test is recommended and routine monitoring is not useful for most people.


